205 related articles for article (PubMed ID: 38255009)
1. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).
Vado Y; Manero-Azua A; Pereda A; Perez de Nanclares G
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38255009
[No Abstract] [Full Text] [Related]
2. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract][Full Text] [Related]
3. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.
de Castro LF; Ovejero D; Boyce AM
Eur J Endocrinol; 2020 May; 182(5):R83-R99. PubMed ID: 32069220
[TBL] [Abstract][Full Text] [Related]
4. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing.
Narumi S; Matsuo K; Ishii T; Tanahashi Y; Hasegawa T
PLoS One; 2013; 8(3):e60525. PubMed ID: 23536913
[TBL] [Abstract][Full Text] [Related]
5. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
[TBL] [Abstract][Full Text] [Related]
6. Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.
Boyce AM; Collins MT
Endocr Rev; 2020 Apr; 41(2):345-70. PubMed ID: 31673695
[TBL] [Abstract][Full Text] [Related]
7. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
Lietman SA; Ding C; Levine MA
J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
[TBL] [Abstract][Full Text] [Related]
9. McCune-Albright syndrome.
Dumitrescu CE; Collins MT
Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
[TBL] [Abstract][Full Text] [Related]
10. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
Völkl TM; Dörr HG
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
[TBL] [Abstract][Full Text] [Related]
11. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
[TBL] [Abstract][Full Text] [Related]
12. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
[TBL] [Abstract][Full Text] [Related]
13. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.
Roszko KL; Guthrie L; Li X; Collins MT; de Castro LF; Boyce AM
J Bone Miner Res; 2023 Mar; 38(3):443-450. PubMed ID: 36593655
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
Spencer T; Pan KS; Collins MT; Boyce AM
Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
[TBL] [Abstract][Full Text] [Related]
16. Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome.
Romanet P; Philibert P; Fina F; Cuny T; Roche C; Ouafik L; Paris F; Reynaud R; Barlier A
J Pediatr; 2019 Feb; 205():281-285.e4. PubMed ID: 30442414
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features of Chilean patients with Fibrous Dysplasia/McCune-Albright Syndrome].
Jiménez C; Schneider P; Baudrand R; García H; Martínez A; Mendoza C; Grob F; Seiltgens C; Florenzano P
Rev Med Chil; 2022 Oct; 150(10):1275-1282. PubMed ID: 37358085
[TBL] [Abstract][Full Text] [Related]
18. Detection of Rare Somatic GNAS Mutation in McCune-Albright Syndrome Using a Novel Peptide Nucleic Acid Probe in a Single Tube.
Lo FS; Chen TL; Chiou CC
Molecules; 2017 Nov; 22(11):. PubMed ID: 29104223
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
